Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: Protocol for an economic evaluation alongside a clinical trial

BMC Geriatrics

Volumn 8, Issue , 2008, Pages

  Watts, Jennifer J ^a,f   McGinley, Jennifer L ^b,f   Huxham, Frances ^c,d,f   Menz, Hylton B ^e,f   Iansek, Robert ^c,d   Murphy, Anna T ^c,d,f   Waller, Emma R ^a   Morris, Meg E ^f  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Kingston Centre   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; ECONOMIC EVALUATION; ELDERLY CARE; FALLING; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MOBILIZATION; PARKINSON DISEASE; PHYSIOTHERAPY; PREVENTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; ECONOMICS; EXERCISE; FEMALE; FITNESS; MALE; OUTCOME ASSESSMENT; PHYSIOLOGY; PROBABILITY; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; WEIGHT LIFTING;

ACCIDENTAL FALLS; ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AUSTRALIA; COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PHYSICAL FITNESS; PROBABILITY; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; WEIGHT LIFTING;

EID: 54949098107     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-8-23     Document Type: Article

References (37)

1. Parkinson's disease. A Samii JG Nutt, The Lancet 2004 363 9423 1783 93 10.1016/S0140-6736(04)16305-8
2. Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study. LML de Lau PCLM Giesbergen, Neurology 2004 63 7 1240 4 15477545
3. Population prevalence and incidence of Parkinson's disease in an Australian community. P Mehta A Kifley, Internal Medicine Journal 2007 37 812 814 10.1111/j.1445-5994.2007.01433.x 17561942
4. Resource use and costs in a Swedish cohort of patients with Parkinson's disease. PS Hagell S Nordling, Movement Disorders 2002 17 6 1213 20 10.1002/mds.10262 12465059
5. Locomotor training in people with Parkinson disease. ME Morris, Physical Therapy 2006 86 10 1426 35 10.2522/ptj.20050277 17012646
6. Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia. WP Goldman JD Baty, Archives of Neurology 1998 55 5 674 80 10.1001/archneur.55.5.674 9605724
7. Apathy in Parkinson's disease. GC Pluck RG Brown, Journal of Neurology, Neurosurgery and Psychiatry 2002 73 6 636 42 10.1136/jnnp.73.6.636
8. Risk of dementia in Parkinson's disease: a community-based, prospective study. D Aarsland K Andersen, Neurology 2001 56 6 730 736 11274306
9. Longitudinal evaluation of economic and physical impact of Parkinson's disease. M Schenkman C Wei Zhu TM Cutson K Whetten-Goldstein, Parkinsonism and Related Disorders 2001 8 1 41 50 10.1016/S1353-8020(00)00079-1
10. The effectiveness of exercise interventions for people with Parkinson's disease: A systematic review and meta-analysis. VA Goodwin SH Richards, Movement Disorders 2008 23 5 631 640 10.1002/mds.21922 18181210
11. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. BH Wood JA Bilclough A Bowron RW Waiker, Joumal of Neurology, Neurosurgery and Psychiatry 2002 72 6 721 5 10.1136/jnnp.72.6.721
12. Prospective assessment of falls in Parkinson's disease. BR Bloem YA Grimbergen M Cramer M Willemsen AH Zwinderman, Journal of Neurology 2001 248 11 950 958 10.1007/s004150170047 11757958
13. Fall risk factors in Parkinson's disease. P Gray K Hildebrand, Journal of Neuroscience Nursing 2000 32 4 222 8 10994536
14. Risk factors for hip fracture among elderly patients with Parkinson's disease. Y Sato M Kaji T Tsuru K Oizumi, Journal of the Neurological Sciences 2001 182 2 89 93 10.1016/S0022-510X(00)00458-5 11137512
15. Fracture risk in patients with parkinsonism: a population based study in Olmstead county, Minnesota. O Johnell ILJ Melton, Age Ageing 1992 21 32 8 10.1093/ageing/21.1.32 1553857
16. Fracture risk after the diagnosis of Parkinson's disease: influence of concomitant dementia. ILJ Melton CL Leibson, Movement Disorders 2006 21 9 1361 7 10.1002/mds.20946 16703587
17. A meta-analysis of six prospective studies of falling in Parkinson's disease. RM Pickering Y Grimbergen, Movement Disorders 2007 22 13 1892 1900 10.1002/mds.21598 17588236
18. Quality of life and care in Parkinson's disease. CE Clarke RM Zobkiw E Gullaksen, Br J Clin Pract 1995 49 6 288 293 8554950
19. Cost of illness and disease severity in a cohort of French patients with Parkinson's Disease. C LePen S Wait, Pharmacoeconomics 1999 16 1 59 69 10.2165/00019053-199916010-00006 10539122
20. Burden of illness in Parkinson's disease. DM Huse MA Schulman, Movement Disorders 2005 20 11 1449 54 10.1002/mds.20609 16007641
21. Direct economic impact of Parkinson's disease: A research survey in the United Kingdom. L Findley M Ajula, Movement Disorders 2003 18 10 1139 89 10.1002/mds.10507 14534917
22. The economic impact of Parkinson's disease: an estimation based on a 3-month prospective analysis. RC Dodel M Singer, Pharmacoeconomics 1998 14 3 299 312 10.2165/00019053-199814030-00006 10186468
23. Cost of Parkinson's disease in Europe. P Lindgren S von Campenhausen, European J of Neurology 2005 12 Suppl 1 68 73 10.1111/j.1468-1331.2005.01197.x
24. Burden of Parkinsonism: A population-based study. M Guttman PM Slaughter, Movement Disorders 2003 18 3 313 36 10.1002/mds.10333 12621635
25. Longitudinal evaluation of economics and physical impact of Parkinson's disease. M Schenkman CW Zhu, Parkinsonism and Related Disorders 2001 8 41 50 10.1016/S1353-8020(00)00079-1
26. Randomized controlled trial of prevention of falls in people aged >75 with severe visual impairment: the VIP trial. AJ Campbell MC Robertson, BMJ 2005 331 7520 817 24 16183652 10.1136/bmj.38601.447731.55
27. Movement disorders in people with Parkinson disease: a model for physical therapy. ME Morris, Physical Therapy 2000 80 578 97 10842411
28. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. MF Folstein SE Folstein, Journal of Psychiatric Research 1975 12 189 198 10.1016/0022-3956(75)90026-6 1202204
29. Parkinsonism: onset, progression and mortality. MM Hoehn MD Yahr, Neurology 1967 17 427 442 10.1159/000137111 6067254
30. Predisposing factors for occasional and multiple falls in older Australians who live at home. ME Morris, The Australian Journal of Physiotherapy 2004 50 3 153 159 15482246
31. Systematic review of definitions and methods of measuring falls in randomised controlled fall prevention trials. K Hauer SE Lamb EC Jorstad C Todd C Becker, Age and Ageing 2006 35 1 5 10 10.1093/ageing/afi218
32. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. SE Lamb EC Jorstad-Stein, J Am Geriatr Soc 2005 53 9 1618 1622 10.1111/j.1532-5415.2005. 53455.x 16137297
33. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. V Peto, Quality of Life Research 1995 4 3 241 8 7613534 10.1007/BF02260863
34. The EQ-5D - a generic quality of life measure - is a useful instrument to measure quality of life in patients with Parkinson's disease. A Schrag, J Neurol Neurosurg Psychiatry 2000 69 67 73 10864606 10.1136/jnnp.69.1.67
35. Unified Parkinson's disease rating scale. S Fahn RL Elton UPDRS Committee, Recent Developments in Parkinson's Disease MacMillan: New York, Fahn S, 1987
36. A review of health-related quality-of-life concepts and measures for Parkinson's disease. AM Damiano C Snyder B Strausser MK Willian, Quality of Life Research 1999 8 3 235 243 10.1023/A:1008823222574 10472154
37. A review of the health-related quality of life and economic impact of Parkinson's disease. CH Dowding CL Shenton SS Salek, Drugs & Aging 2006 23 9 693 721 10.2165/00002512-200623090-00001 17020395